Jesse David Troy

Accounting for Selection Bias due to Missing Data in Evaluation of the Impact of Oncotype DX Recurrence Scoring on Adjuvant Chemotherapy Receipt among Breast Cancer Patients in the National Cancer Database.

Allison Reagan (2020) (Advisor)

The Interplay Between Age, Comorbidity, and Timing of Androgen Deprivation Therapy on Survival After Recurrent Prostate Cancer

Marissa Trotta (2021) (Advisor)

Using Multiple Imputation and Pattern Mixture Models to Evaluate Assumptions About Missing Data in the ACCeNT Trial

Ryan Milligan (2021) (Advisor)

Analyzing the Impact of Missing Data from a Clinical Trial of Stem Cell Therapy for Cerebral Palsy Patients

Yiyang Zhang (2022) (Committee member)

Very Low Birth Weight (VLBW) Preterm infant Health Outcomes with Bundle Care in the Neonatal Intensive Care Unit

Yifeng Tang (2022) (Committee member)

Investigating the differences between the Family-Based association test and General Linear Mixed Model for related data

Chuxuan Sun (2022) (Committee member)

Identifying the risk of the Second Primary Malignancies Among Primary Malignant Breast Cancer Survivors in the United States with Grouped-Lasso Cox Model in SEER

Committee member

Si Zhou (2022) (Committee member)

Assessing the adequacy of lymph node yield (LNY) for head and neck cancer

Clinical Research Training Program

Julia Messina, MD (2020) (Committee member)

Genomic Characterization of Enterococcal Bloodstream Isolates in Hematologic Malignancies

Emily Eichenberger, MD (2022) (Committee member)

Gram-negative bacteremia in solid organ transplant recipients: clinical characteristics and outcomes as compared to non-transplant recipients

Diana Ximena Nichols-Vinueza, MD (2022) (Committee member)

Assessment of Bone Density in Children with Food Allergies